Systemic treatment paradigms for unresectable and advanced hepatocellular carcinoma in Europe
Summary The management of unresectable and advanced hepatocellular carcinoma (HCC) has been transformed by the introduction of immune checkpoint inhibitor-based combinations, which have improved response and survival and expanded first-line treatment options. The availability of multiple effective regimens has introduc...